Daxor ROA 2010-2011 | DXR

Current and historical return on assets (ROA) values for Daxor (DXR) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Daxor ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2011-12-31 $-0.01B $0.09B -6.61%
2011-09-30 $0.00B $0.09B -3.26%
2011-06-30 $0.00B $0.10B 4.37%
2011-03-31 $0.00B $0.09B 4.57%
2010-12-31 $0.01B $0.09B 5.81%
2010-09-30 $0.00B $0.09B 2.44%
2010-06-30 $0.00B $0.08B 2.48%
2010-03-31 $0.01B $0.09B 10.09%
2009-12-31 $0.01B $0.08B 8.22%
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.051B $0.000B
Daxor Corporation is a medical device manufacturing corporation with additional biotech services.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $20.102B 19.21
Encompass Health (EHC) United States $12.125B 24.22
DaVita (DVA) United States $9.680B 13.84
Elanco Animal Health (ELAN) United States $8.923B 19.96
Chemed (CHE) United States $6.486B 21.72
RadNet (RDNT) United States $5.188B 187.36
Option Care Health (OPCH) United States $4.596B 19.67
Addus HomeCare (ADUS) United States $2.119B 22.84
LifeStance Health (LFST) United States $2.116B 0.00
Astrana Health (ASTH) United States $1.644B 57.51
Aveanna Healthcare Holdings (AVAH) United States $1.479B 27.23
U.S Physical Therapy (USPH) United States $1.304B 32.62
Pennant (PNTG) United States $0.873B 30.80
Atai Life Sciences (ATAI) Germany $0.777B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.060B 0.00
Ontrak (OTRK) United States $0.001B 0.00
Psychemedics (PMD) United States $0.000B 0.00